Abu Dhabi Department of Health welcomed the flight carrying the first global shipment of Sotrovimab’ an investigational monoclonal antibody therapy medication that fights SARS-CoV-2.
From L-R: Gizem Akalin, Managing Director and VP of GlaxoSmithKline; Patrick Moody, British Ambassador to the UAE; HE Dr. Jamal Mohamed Kaabi, Undersecretary, Abu Dhabi Department of Health; Rashed Al Qubaisi,CEO, Etihad Aviation Group; and Martin Drew, SVP Etihad Sales & Cargo.
